<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04757675</url>
  </required_header>
  <id_info>
    <org_study_id>Premedication s-ketamin</org_study_id>
    <nct_id>NCT04757675</nct_id>
  </id_info>
  <brief_title>S-ketamin Premedication in Pediatric EENT Surgery</brief_title>
  <official_title>A Comparison of S-ketamin, Dexmedetomidine, and Combination as Premedication in Children Undergoing ENT Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eye &amp; ENT Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eye &amp; ENT Hospital of Fudan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to investigate the effects of premedication (intranasal or intravenous administration)&#xD;
      of s-ketamin, dexmedetomidine, and combination for premedication in children undergoing ENT&#xD;
      surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Three hundred children aged between 2 and 12 years were randomly allocated to one of five&#xD;
      groups: 0.3 μg/kg intravenous injection s-ketamin; 0.5 μg/kg intravenous injection s-ketamin;&#xD;
      2 μg/kg intranasal s-ketamin group; 1 μg/kg intranasal s-ketamin + 1 μg/kg intranasal&#xD;
      dexmedetomidine group; 0.5 μg/kg intranasal s-ketamin + 2 μg/kg intranasal dexmedetomidine&#xD;
      group.&#xD;
&#xD;
      The modified Yale Preoperative Anxiety Scale (m-YPAS) was used to assess preoperative anxiety&#xD;
      at 1, 5, 10, 20, and 30min after premedication. A 4-point emotional state score was used to&#xD;
      evaluate participators when they were separated from their parents and their response to&#xD;
      intravenous cannulation or facemask application. Agitation scores (Pediatric Anesthesia&#xD;
      Emergence Delirium [PAED] scale) and POV was assessed in the postanesthetic care unit (PACU).&#xD;
      Times to endotracheal tube or laryngeal mask airway removal, discharge from the PACU, and&#xD;
      patients' satisfaction degree were also assessed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The modified Yale Preoperative Anxiety Scale</measure>
    <time_frame>1 min after premedication</time_frame>
    <description>A validated observational tool for assessing children's anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The modified Yale Preoperative Anxiety Scale</measure>
    <time_frame>5 min after premedication</time_frame>
    <description>A validated observational tool for assessing children's anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The modified Yale Preoperative Anxiety Scale</measure>
    <time_frame>10 min after premedication</time_frame>
    <description>A validated observational tool for assessing children's anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The modified Yale Preoperative Anxiety Scale</measure>
    <time_frame>20 min after premedication</time_frame>
    <description>A validated observational tool for assessing children's anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The modified Yale Preoperative Anxiety Scale</measure>
    <time_frame>30 min after premedication</time_frame>
    <description>A validated observational tool for assessing children's anxiety</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parental Separation Anxiety Scale (PSAS)</measure>
    <time_frame>30 min after premedication</time_frame>
    <description>= easy separation&#xD;
= whimpers, but is easily reassured, not clinging&#xD;
= cries and cannot be easily reassured, but not clinging to parents&#xD;
= crying and clinging to parents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emotional State Scale</measure>
    <time_frame>15 min after premedication</time_frame>
    <description>Successful venous cannulation was defined as an ESS-4 ≤2 at the time of attempted cannulation, regardless of whether the vein was actually cannulated on the first attempt.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Emotions</condition>
  <condition>Separation Anxiety</condition>
  <condition>Pain, Procedural</condition>
  <arm_group>
    <arm_group_label>0.3 SK iv</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.3 μg/kg intravenous injection s-ketamin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.5 SK iv</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5 μg/kg intravenous injection s-ketamin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 SK in</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 μg/kg intranasal s-ketamin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 SK in + 1 DEX in</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 μg/kg intranasal s-ketamin + 1 μg/kg intranasal dexmedetomidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.5 SK in + 2 DEX in</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5 μg/kg intranasal s-ketamin + 2 μg/kg intranasal dexmedetomidine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S-ketamine 0.3</intervention_name>
    <description>0.3 μg/kg intravenous injection s-ketamin</description>
    <arm_group_label>0.3 SK iv</arm_group_label>
    <other_name>Jiangsu Hengrui Medicine Co.,Ltd.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S-ketamine 0.5</intervention_name>
    <description>0.5 μg/kg intravenous injection s-ketamin</description>
    <arm_group_label>0.5 SK iv</arm_group_label>
    <other_name>Jiangsu Hengrui Medicine Co.,Ltd.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S-ketamine 2</intervention_name>
    <description>2 μg/kg intranasal s-ketamin</description>
    <arm_group_label>2 SK in</arm_group_label>
    <other_name>Jiangsu Hengrui Medicine Co.,Ltd.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S-ketamine 1+Dexmedetomidine 1</intervention_name>
    <description>1 μg/kg intranasal s-ketamin + 1 μg/kg intranasal dexmedetomidine</description>
    <arm_group_label>1 SK in + 1 DEX in</arm_group_label>
    <other_name>Jiangsu Hengrui Medicine Co.,Ltd.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S-ketamine 0.5 +Dexmedetomidine 2</intervention_name>
    <description>0.5 μg/kg intranasal s-ketamin + 2 μg/kg intranasal dexmedetomidine</description>
    <arm_group_label>0.5 SK in + 2 DEX in</arm_group_label>
    <other_name>Jiangsu Hengrui Medicine Co.,Ltd.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  After obtaining the informed consent from their parents or proxies, the children aged&#xD;
             2 to 12 years, scheduled for elective ENT surgery, of American Society of&#xD;
             Anesthesiologists (ASA) I or II were enrolled in this study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Congenital heart diseases, congenital dysplasia, obstructive sleep apnea syndrome,&#xD;
             upper respiratory tract infection, body mass index (BMI) ≥25, allergy to S-ketamin or&#xD;
             dexmedetomidine, and severe liver or kidney disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hui Qiao, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eye and ENT Hospital of Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hui Qiao, M.D.</last_name>
    <phone>8615900598163</phone>
    <email>theyellow@163.com</email>
  </overall_contact>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 13, 2021</study_first_submitted>
  <study_first_submitted_qc>February 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2021</study_first_posted>
  <last_update_submitted>February 13, 2021</last_update_submitted>
  <last_update_submitted_qc>February 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Eye &amp; ENT Hospital of Fudan University</investigator_affiliation>
    <investigator_full_name>Hui Qiao</investigator_full_name>
    <investigator_title>Clinical Anesthesiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Procedural</mesh_term>
    <mesh_term>Anxiety, Separation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Esketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

